Biggest News Aggregation in the World
📰 Key Impacts News

Key Impacts News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Key Impacts. Real-time updates on events, politics, business and more.

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration

START study provides real-world data for AUSTEDO with the use of a 4-week patient titration kit for adults with tardive dyskinesia (TD), including utilization and patient satisfactionAUSTEDO is the only vesicular monoamine transporter 2 (VMAT2) inhibitor with 3-year long-term data1,2 approved for adults with TD and...
Andrew Cutler Sanjeev Sharma Eric Hughes Yael Ashman Drug Administration Psych Congress Elevate

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023

START study provides real-world data for AUSTEDO with the use of a 4-week patient titration kit for adults with tardive dyskinesia , including utilization and patient satisfaction AUSTEDO is the... | June 10, 2023
United States Andrew Cutler Eric Hughes Drug Administration Teva Pharmaceuticals Teva Neuroscience Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science